Text Size
781 studies found for:    FDG

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Terminated Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation
Conditions: Lung Cancer;   SCLC;   NSCLC
Intervention: Other: 18F-deoxyglucose (FDG)
2 Completed FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer
Conditions: Malignant Pleural Effusion;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Drug: carboplatin;   Drug: docetaxel;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel;   Procedure: computed tomography;   Procedure: positron emission tomography;   Radiation: fludeoxyglucose F 18;   Other: imaging biomarker analysis
3 Unknown † A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.
Condition: Glioblastoma
Intervention: Procedure: FDG-PET
4 Active, not recruiting Accuracy of FDG-PET Scanning to Diagnose Malignant Thyroid Nodules
Condition: Thyroid Neoplasms
Intervention: Other: FDG-PET Scan
5 Recruiting 18F-FDG PET/CT for IgG4-Related Disease
Condition: Autoimmune Disease
Intervention: Drug: 18F-FDG
6 Completed Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer.
Condition: Ovarian Cancer
Intervention: Procedure: 1: FDG PET
7 Active, not recruiting Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Procedure: PET/CT scan;   Drug: 18F-FDG Injection;   Procedure: Preoperative 18F-FDG PET/CT Scan;   Drug: 18F-FDG for patients with Bladder Cancer;   Procedure: Surgical Procedure;   Procedure: Specimen PET/CT Scan
8 Unknown † Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.
Condition: Head and Neck Cancer
Intervention: Other: CT-FDG/PET scan of the head-and-neck region
9 Completed Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI
Conditions: Kidney Neoplasms;   Carcinoma, Renal Cell;   Kidney (Renal Cell) Cancer
Interventions: Procedure: FDG PET CT;   Procedure: DCE MRI;   Drug: F-18 Fluoro-deoxi-glucose;   Drug: Gadolinium-DTPA;   Drug: Sunitinib
10 Withdrawn Fludeoxyglucose F 18 PET/CT Scans in Predicting Therapy Response in Patients With Stage IIIA Non-Small Cell Lung Cancer Undergoing Chemoradiation
Condition: Stage IIIA Non-small Cell Lung Cancer
Interventions: Procedure: positron emission tomography/computed tomography (PET/CT);   Radiation: fludeoxyglucose F 18
11 Completed FDG-PET/CT in the Evaluation of Patients With Suspected Cholecystitis
Condition: Cholecystitis
Intervention: Drug: 18FDG (an FDA-approved radiopharmaceutical)
12 Completed
Has Results 		A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With Erlotinib
Condition: Non-Small Cell Lung Cancer
Interventions: Other: 2-deoxy-2-[18F]fluoro-D-glucose (FDG);   Other: 3'-deoxy-3'-[18F]fluorothymidine (FLT);   Drug: erlotinib HCl
13 Recruiting Diagnostic Performance of 18F-FDG-PET and Diffusion-weighted MRI in the Assessment of Stage IB to IIB2 Cervical Squamous-cell Carcinoma Response to Concomitant Radiochemotherapy and Brachytherapy
Condition: Squamous-cell Cervical Carcinoma Stage IB2 to IIB Without Spread to Lymph Nodes or Metastasis
Intervention: Device: 18F-FDG-PET
14 Completed Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET) in Cancer Associated Venothromboembolism
Condition: Venothromboembolism
Intervention: Procedure: FDG-PET/CT
15 Recruiting Performance of 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in the Diagnosis of Indeterminate Adrenal Tumors on Conventional Imaging: A French Prospective Multicentric Study
Condition: Adrenal Gland Neoplasms
Intervention: Other: FDG-PET scan
16 Active, not recruiting Positron Emission Tomography Using Fluoromisonidazole F 18 and Fludeoxyglucose F 18 to Find Oxygen in Tumor Cells of Patients Undergoing Treatment for Newly Diagnosed Stage IB, Stage II, Stage III, or Stage IV Cervical Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Squamous Cell Carcinoma;   Stage IB Cervical Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer
Interventions: Other: 18F-fluoromisonidazole;   Radiation: fludeoxyglucose F 18;   Procedure: positron emission tomography;   Other: tissue oxygen measurement
17 Completed 18FDG-PET Imaging to Detect Changes in Airways Inflammation in Cystic Fibrosis Patients
Condition: Cystic Fibrosis
Intervention: Other: 18-FDG
18 Active, not recruiting 18F-Fluoromisonidazole and Fludeoxyglucose F 18 PET/CT Scans in Assessing Oxygen in Tumor Tissue of Patients With Soft Tissue Sarcoma Undergoing Chemotherapy With or Without Radiation Therapy
Conditions: Recurrent Adult Soft Tissue Sarcoma;   Stage I Adult Soft Tissue Sarcoma;   Stage II Adult Soft Tissue Sarcoma;   Stage III Adult Soft Tissue Sarcoma;   Stage IV Adult Soft Tissue Sarcoma
Interventions: Radiation: fludeoxyglucose F 18;   Other: 18F-fluoromisonidazole;   Procedure: positron emission tomography;   Procedure: computed tomography;   Other: laboratory biomarker analysis
19 Terminated FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy
Condition: Lung Cancer
Interventions: Drug: chemotherapy;   Radiation: fludeoxyglucose F 18
20 Recruiting Fludeoxyglucose F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Cell Carcinoma;   Cervical Small Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Endometrial Clear Cell Carcinoma;   Endometrial Papillary Serous Carcinoma;   Stage I Endometrial Carcinoma;   Stage IB Cervical Cancer;   Stage II Endometrial Carcinoma;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Cervical Cancer;   Stage III Endometrial Carcinoma;   Stage IVA Cervical Cancer
Interventions: Drug: ferumoxtran-10;   Procedure: diagnostic lymphadenectomy;   Procedure: axillary lymph node biopsy;   Procedure: 3-Tesla magnetic resonance imaging;   Procedure: positron emission tomography/computed tomography;   Radiation: fludeoxyglucose F 18
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years